loading page

Psychosocial function of Dutch children with cancer and their caregivers during different phases of the COVID-19 pandemic
  • +6
  • Marloes van Gorp,
  • Heleen Maurice-Stam,
  • Layla Teunissen,
  • Ellen Kilsdonk,
  • Jennifer van Dijk,
  • Mirjam Sulkers,
  • Wim Tissing,
  • Raphaële Van Litsenburg,
  • Martha A. Grootenhuis
Marloes van Gorp
Princess Máxima Center for pediatric oncology
Author Profile
Heleen Maurice-Stam
Princess Máxima Center for pediatric oncology
Author Profile
Layla Teunissen
Princess Máxima Center for pediatric oncology
Author Profile
Ellen Kilsdonk
Princess Maxima Center for Pediatric Oncology
Author Profile
Jennifer van Dijk
Princess Maxima Center for Pediatric Oncology
Author Profile
Mirjam Sulkers
Princess Maxima Center for Pediatric Oncology
Author Profile
Wim Tissing
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Author Profile
Raphaële Van Litsenburg
Princess Maxima Center for Pediatric Oncology
Author Profile
Martha A. Grootenhuis
Princess Máxima Center for Pediatric Oncology
Author Profile

Abstract

We compared psychosocial functioning of children with cancer and their caregivers in several phases of the COVID-19 pandemic to before COVID-19. One or more questionnaires on health-related quality of life (HRQoL) or fatigue of children or distress of their caregivers was available from 1644 families. In children with cancer, HRQoL was stable throughout the COVID-19 pandemic. Fatigue was slightly lower and sleep somewhat better during the pandemic than before. Caregiver distress was lower in the first pandemic phase, but increased to pre-COVID-19 levels in later phases, indicating that the length and consequences of the pandemic may be weighing on them.
03 Sep 2021Submitted to Pediatric Blood & Cancer
03 Sep 2021Submission Checks Completed
03 Sep 2021Assigned to Editor
06 Sep 2021Reviewer(s) Assigned
01 Oct 2021Review(s) Completed, Editorial Evaluation Pending
02 Oct 2021Editorial Decision: Revise Major
01 Nov 2021Submission Checks Completed
01 Nov 2021Assigned to Editor
01 Nov 20211st Revision Received
02 Nov 2021Reviewer(s) Assigned
02 Dec 2021Review(s) Completed, Editorial Evaluation Pending
04 Dec 2021Editorial Decision: Accept
Apr 2022Published in Pediatric Blood & Cancer volume 69 issue 4. 10.1002/pbc.29535